Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Sunrun
RUN
$2.15B
| $2M | 0.01% |
+340,472
| New | +$2.8M |
|
1352
PUT
Samsara
IOT
$23.5B
| $1.99M | 0.01% |
52,000
+24,400
| +88% | +$1.14M |
|
1353
PUT
Zoetis
ZTS
$31.9B
| $1.99M | 0.01% |
12,100
+5,200
| +75% | +$865K |
|
1354
Walker & Dunlop
WD
$1.36B
| $1.99M | 0.01% |
23,323
-28,785
| -55% | -$2.58M |
|
1355
PUT
Phillips 66
PSX
$96.5B
| $1.99M | 0.01% |
16,100
+6,500
| +68% | +$801K |
|
1356
CALL
Atkore
ATKR
$3.16B
| $1.99M | 0.01% |
33,100
+6,000
| +22% | +$429K |
|
1357
Baxter International
BAX
$13.7B
| $1.98M | 0.01% |
+57,944
| New | +$1.89M |
|
1358
The Ensign Group
ENSG
$10.5B
| $1.98M | 0.01% |
15,303
+1,532
| +11% | +$203K |
|
1359
Valmont Industries
VMI
$9.29B
| $1.97M | 0.01% |
6,916
-927
| -12% | -$302K |
|
1360
SentinelOne
S
$7.14B
| $1.97M | 0.01% |
108,230
-15,120
| -12% | -$328K |
|
1361
PUT
Duolingo
DUOL
$6.87B
| $1.96M | 0.01% |
6,300
-300
| -5% | -$103K |
|
1362
CALL
J.M. Smucker
SJM
$13.5B
| $1.95M | 0.01% |
16,500
+13,600
| +469% | +$1.47M |
|
1363
Blend Labs
BLND
$355M
| $1.95M | 0.01% |
582,121
+461,496
| +383% | +$1.68M |
|
|
BPMC
1364
DELISTED
Blueprint Medicines
BPMC
| $1.95M | 0.01% |
22,011
+13,911
| +172% | +$1.36M |
|
1365
PUT
Las Vegas Sands
LVS
$30.4B
| $1.95M | 0.01% |
50,400
+35,300
| +234% | +$1.56M |
|
1366
CALL
InterDigital
IDCC
$8.8B
| $1.94M | 0.01% |
9,400
-6,300
| -40% | -$1.27M |
|
1367
PUT
BWX Technologies
BWXT
$13.7B
| $1.94M | 0.01% |
19,700
-18,100
| -48% | -$1.96M |
|
1368
CALL
Generac Holdings
GNRC
$12B
| $1.94M | 0.01% |
15,300
+7,600
| +99% | +$1.09M |
|
1369
PUT
Futu Holdings
FUTU
$16.2B
| $1.93M | 0.01% |
18,900
-23,100
| -55% | -$2.37M |
|
1370
PUT
Pfizer
PFE
$159B
| $1.93M | 0.01% |
76,200
+64,300
| +540% | +$1.68M |
|
1371
Avery Dennison
AVY
$13.9B
| $1.93M | 0.01% |
10,839
-19,824
| -65% | -$3.65M |
|
1372
PUT
Suncor Energy
SU
$78.8B
| $1.93M | 0.01% |
49,800
-12,600
| -20% | -$481K |
|
1373
Arch Capital
ACGL
$34.5B
| $1.93M | 0.01% |
+20,025
| New | +$1.85M |
|
1374
OppFi
OPFI
$603M
| $1.92M | 0.01% |
206,508
-69,823
| -25% | -$778K |
|
1375
CALL
Nice
NICE
$5.87B
| $1.91M | 0.01% |
12,400
+1,400
| +13% | +$224K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.